全国政协委员彭军：从罕见病到就医体验 心系“急难愁盼”

Core Viewpoint - The article emphasizes the importance of addressing the needs of rare disease patients, highlighting the ongoing efforts to improve their medical care and support systems [1][3]. Group 1: Rare Disease Advocacy - National Committee member Peng Jun is focused on improving the multi-layered support system for rare disease patients, particularly children from impoverished families [3][4]. - In 2023, Peng submitted proposals aimed at enhancing the diagnostic capabilities for rare diseases, with a specific focus on children's healthcare in 2025 [3][4]. Group 2: Patient Experiences and Challenges - Rare disease patients face an average diagnosis time of over 4 years, often experiencing multiple misdiagnoses before receiving correct treatment [4]. - Many families struggle with the high costs of treatment, with some patients facing annual out-of-pocket expenses of 3 to 4 million RMB before certain medications were included in the national insurance [4][7]. Group 3: Policy Changes and Improvements - In 2024, 15 rare disease medications were added to the national insurance directory, significantly reducing patient costs from 300,000 to 400,000 RMB annually to 50,000 to 60,000 RMB [7]. - The article notes that there is increasing recognition and support for rare disease treatment and care from government agencies, indicating positive changes in the healthcare landscape [4][7]. Group 4: Broader Healthcare Initiatives - Peng Jun is advocating for the introduction of prescription rights for specialized nurses to improve patient experiences in routine medical scenarios, aiming to reduce wait times and enhance overall healthcare accessibility [7].